Integration of structure-based drug design approach to generate novel thymidine kinase inhibitor against Vaccinia virus
Crossref DOI link: https://doi.org/10.1007/s12039-026-02474-2
Published Online: 2026-04-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Das, Hemanga Kumar
Parasar, Deep Prakash
Raval, Sagar
Kumar, Krishan
Das, Akan
Text and Data Mining valid from 2026-04-30
Version of Record valid from 2026-04-30
Article History
Received: 24 April 2025
Revised: 6 August 2025
Accepted: 1 September 2025
First Online: 30 April 2026